Wiz vs BioCatch

By valuation, Wiz is the larger company at $32B versus $1.3B — a 24.6x difference. Size can also be measured by team: Wiz employs 1250 people while BioCatch has 100-500 employees.

Wiz has raised more in total funding at $1.9B, compared to BioCatch's $213M — a gap of $1.7B. Combined, the two companies have completed 6 known funding rounds.

Wiz leads with an Awaira Score of 95/100, while BioCatch sits at 80/100. That 15-point gap reflects real differences in funding, scale, and traction — it's not a vanity metric.

Wiz was founded by Assaf Rappaport in 2020. BioCatch was founded by Avi Turgeman in 2011. Visit each company's profile on Awaira for a full founder biography.

Wiz: Wiz is an Israeli cloud security company founded in 2020 that specializes in cloud infrastructure entitlement management and security. The platform provides real-time visibility and control across cloud environments, focusing on identifying and remediating security risks in Infrastructure-as-a-Service (IaaS) platforms including AWS, Azure, and Google Cloud. Wiz's core offering combines cloud asset inventory, vulnerability management, and identity and access management capabilities to detect misconfigurations and unauthorized access paths. The company employs graph-based analysis to map attack paths and prioritize remediation efforts based on actual risk exposure rather than theoretical vulnerabilities. Wiz has achieved significant market traction, reaching a $32 billion valuation following substantial funding rounds totaling $1,900 million. The company serves enterprise customers across financial services, technology, and healthcare sectors. Its competitive positioning emphasizes speed of deployment and accuracy in threat detection compared to traditional cloud security solutions. Wiz demonstrates strong growth trajectory with rapid customer acquisition and expansion of platform capabilities. The company has been acquired, representing a significant exit in the cloud security market. Its success reflects growing enterprise demand for comprehensive cloud security solutions as organizations accelerate cloud migration and require sophisticated tools to manage expanding attack surfaces and identity-based threats in distributed cloud infrastructures. Wiz's graph-based approach to mapping attack paths within cloud environments differentiates it from traditional vulnerability scanning tools. BioCatch: BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions. The Tel Aviv company processes behavioural signals from hundreds of millions of user sessions monthly, building individual profiles that flag deviations indicating fraud.\n\nThe company raised approximately $213 million in venture funding including a Series D led by Tiger Global, reaching a valuation exceeding $1 billion. BioCatch counts over 30 tier-one banks globally among its clients including American Express, NatWest, and Lloyds Banking Group, with deployments protecting online banking and mobile banking sessions from fraud that bypasses traditional authentication controls. The platform is particularly effective against malware-assisted fraud and social engineering scams where the genuine account holder is unknowingly manipulated.\n\nBioCatch competes in the behavioural biometrics and fraud intelligence market alongside ThreatMetrix (now LexisNexis Risk Solutions), Sift, and Sardine, as well as traditional fraud management platforms from FICO and SAS. Its differentiation is the depth of its behavioural feature engineering from passive interaction signals that do not require active user participation, creating a fraud layer that operates continuously without adding friction to legitimate user journeys. The growing prevalence of authorised push payment fraud and social engineering attacks in European banking has expanded the relevant use case for BioCatch beyond traditional account takeover detection.

BioCatch got there first, launching in 2011 — that's 9 years of extra runway. Wiz didn't arrive until 2020. In AI, that kind of head start means more training data, deeper customer relationships, and a bigger talent moat.

Wiz has about 1250 employees; BioCatch has about 100-500. A bigger team usually means more revenue or heavier VC backing, but in AI, small teams can build at massive scale.

Yes — they're direct rivals. Both Wiz and BioCatch compete in AI Security, targeting many of the same buyers. If you're evaluating one, you should be looking at the other.